trending Market Intelligence /marketintelligence/en/news-insights/trending/Z9lGsH8xZBz7nqXayz4EEQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Aesthetic Medical prices $30M Nasdaq IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Aesthetic Medical prices $30M Nasdaq IPO

Aesthetic Medical International Holdings Group Ltd. priced its IPO of 2.5 million American depositary shares to raise about $30 million in gross proceeds.

The Shenzhen, China-based company, which provides aesthetic surgery services such as eye and nose surgery, breast augmentation and liposuction, will sell each ADS in the IPO at $12. Each ADS represents 3 ordinary shares of the company.

Aesthetic Medical's ADSs started trading on the Nasdaq Global Market on Oct. 25 under the ticker symbol AIH and were down 30.5% to $8.34 as of 11:58 a.m. on the first day of trading.

The company has granted underwriters the option to purchase up to an additional 375,000 ADSs. Full exercise of the option will increase the gross proceeds to about $34.5 million.

Pengwu Zhou is chariman and CEO of Aesthetic Medical.

Aesthetic Medical expects to close the IPO on Oct. 29, subject to closing conditions.

Cantor Fitzgerald & Co., Haitong International Securities Co. Ltd. and Prime Number Capital LLC are joint book-runners for the IPO. Maxim Group LLC, Tiger Brokers (NZ) Ltd. and Valuable Capital Ltd. are co-managers for the offering.